The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

Role of Race, Rurality, and Age in Human Papillomavirus Vaccine Initiation among US Women

Authors: Casey Macander, MS, Hui Wang, MS, Marcelo Galafassi, MS, ATC, Graham M. Jones, BS, Antara Das, MPH, Alta Willaert, BS, Randi Henderson-Mitchell, PhD, MBA, John C. Higginbotham, PhD, MPH

Abstract

Objectives: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, with a lifetime prevalence of more than 80%. HPV is associated with cervical cancer, which affects thousands of US women each year. A vaccine was introduced in 2006 to mitigate the prevalence and mortality of HPV-associated cancers. Although HPV vaccine adherence has increased over time, disparities in vaccine uptake exist among adolescents, and likely within adult communities. This study explored the impact of race/ethnicity, rural classification, and age on vaccine initiation among adult women in the United States.

Methods: The final sample included N = 4666 females aged 18 to 43 years from the 2022 National Health Interview Survey. A logistic regression model explored the association of race/ethnicity, rural classification, and age with HPV vaccine initiation.

Results: Only 40.1% of our sample ever received an HPV vaccine. Urban residents were significantly more likely than rural residents to have ever gotten an HPV vaccine. Hispanic, Black, and Asian participants had significantly lower HPV vaccine initiation rates compared with their White counterparts. Finally, as age increased, HPV vaccine initiation decreased.

Conclusions: Efforts to increase HPV vaccine uptake for future generations of women and girls in the United States should focus on rural communities, as well as Black, Hispanic, and Asian racial minorities. Because so many women within our sample had not received any HPV vaccine, we must emphasize the importance of HPV testing and cervical cancer screening, especially among aging women.
Posted in: Sexually Transmitted Diseases & Infections of Reproductive Organs1

Full Article

Having trouble viewing the article content below? Click here to open it directly.

Images

Download Image

Download Image

Download Image

References

1. Chesson HW, Dunne EF, Hariri S, et al. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 2014;41:660–664.
 
2. Centers for Disease Control and Prevention. Pinkbook. HPV. Epidemiology of vaccine preventable diseases. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-11-human-papillomavirus.html?CDC_AAref_Val=https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html. Published September 21, 2022. Accessed July 11, 2024.
 
3. World Health Organization. Human papillomavirus and cancer. https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer. Published March 5, 2024. Accessed July 11, 2024.
 
4. USCS Data Visualizations. https://gis.cdc.gov/cancer/USCS/#/AtAGlance/. Accessed July 11, 2024. .
 
5. Centers for Disease Control and Prevention. Cancers linked with HPV each year. https://www.cdc.gov/cancer/hpv/cases.html. Published April 25, 2024. Accessed July 11, 2024.
 
6. Barraza L, Weidenaar K, Campos-Outcalt D, et al. Human papillomavirus and mandatory immunization laws. Public Health Rep 2016;131:728–731.
 
7. Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J Clin Invest 2006;116: 1167–1173.
 
8. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1–24.
 
9. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2016;65:1405–1408.
 
10. Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2019;68:698–702.
 
11. US Department of Health and Human Services, Healthy People 2030. HPV vaccination. https://odphp.health.gov/healthypeople/tools-action/browse-evidence-based-resources/hpv-vaccination. Accessed July 18, 2024.
 
12. US Department of Health and Human Services, Healthy People 2020. Immunization and infectious diseases. https://www.cdc.gov/nchs/data/hpdata2020/hp2020mcr-c23-iid.pdf. Accessed July 18, 2024.
 
13. Boakye EA, Fedorovich Y, White M, et al. Rural-urban disparities in HPV vaccination coverage among adolescents in the central part of the state of Illinois, USA. J Community Health 2023;48:24–29.
 
14. McElfish PA, Narcisse MR, Felix HC, et al. Race, nativity, and sex disparities in human papillomavirus vaccination among young adults in the United States. J Racial Ethn Health Disparities 2021;8:1260–1266.
 
15. Pingali C, Yankey D, Elam-Evans LD, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2020. Morb Mortal Wkly Rep 2021;70:1183–1190.
 
16. Henley SJ. Invasive cancer incidence, 2004–2013, and deaths, 2006–2015. MMWR Surveill Summ 2017;66:1–13.
 
17. Viens LJ, Henley J, Watson M, et al. Human papillomavirus-associated cancers — United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016;65:661–666.
 
18. Yoo W, Kim S, Huh WK, et al. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States. PLoS ONE 2017;12:e0172548.
 
19. Zahnd WE, James AS, Jenkins WD, et al. Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomark Prev 2018;27:1265–1274.
 
20. National Cancer Institute. Cancer trends progress report. HPV vaccination. https://progressreport.cancer.gov/prevention/hpv_immunization. Accessed July 18, 2024.
 
21. Centers for Disease Control and Prevention. HPV vaccination. Human papillomavirus (HPV). https://www.cdc.gov/hpv/vaccines/index.html. Published July 9, 2024. Accessed July 18, 2024.
 
22. Centers for Disease Control and Prevention. ACIP shared clinical decision-making recommendations. https://www.cdc.gov/acip/vaccine-recommendations/shared-clinical-decision-making.html. Published June 27, 2024. Accessed July 18, 2024.
 
23. National Center for Health Statistics. National Health Interview Survey. https://www.cdc.gov/nchs/nhis/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fnchs%2Fnhis%2Findex.ht. Published July 18, 2024. Accessed July 18, 2024.
 
24. National Center for Health Statistics. NHIS methods. https://www.cdc.gov/nchs/nhis/about/nhis-methods.html?CDC_AAref_Val=https://www.cdc.gov/nchs/nhis/methods.htm. Published June 14, 2021. Accessed July 18, 2024.
 
25. National Center for Health Statistics. 2022 NHIS questionnaires, datasets, and documentation. https://www.cdc.gov/nchs/nhis/documentation/2022-nhis.html?CDC_AAref_Val=https://www.cdc.gov/nchs/nhis/2022nhis.htm. Published April 10, 2024. Accessed July 18, 2024.
 
26. National Center for Health Statistics. NCHS urban-rural classification scheme for counties. https://www.cdc.gov/nchs/data-analysis-tools/urban-rural.html?CDC_AAref_Val=https://www.cdc.gov/nchs/data_access/urban_rural.htm. Published April 6, 2023. Accessed July 18, 2024.
 
27. Swiecki-Sikora AL, Henry KA, Kepka D. HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health 2019;35:506–517.
 
28. Pingali C, Yankey D, Elam-Evans LD, et al. Vaccination coverage among adolescents aged 13–17 years — National Immunization Survey–Teen, United States, 2022. MMWR Morb Mortal Wkly Rep 2023;72:912–919.